303 related articles for article (PubMed ID: 25386859)
1. Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging.
Menderes G; Azodi M; Schwartz P; Silasi DA
Int J Gynecol Cancer; 2015 Jan; 25(1):160-5. PubMed ID: 25386859
[TBL] [Abstract][Full Text] [Related]
2. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
[TBL] [Abstract][Full Text] [Related]
4. Lower-extremity lymphedema following management for endometrial and cervical cancer.
Mendivil AA; Rettenmaier MA; Abaid LN; Brown JV; Micha JP; Lopez KL; Goldstein BH
Surg Oncol; 2016 Sep; 25(3):200-4. PubMed ID: 27566023
[TBL] [Abstract][Full Text] [Related]
5. Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging.
Menderes G; Azodi M; Clark L; Xu X; Lu L; Ratner E; Schwartz PE; Rutherford TJ; Santin AD; Silasi DA
Int J Gynecol Cancer; 2014 Jul; 24(6):1118-25. PubMed ID: 24927247
[TBL] [Abstract][Full Text] [Related]
6. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience.
Volpi L; Sozzi G; Capozzi VA; Ricco' M; Merisio C; Di Serio M; Chiantera V; Berretta R
Int J Gynecol Cancer; 2019 Feb; 29(2):312-319. PubMed ID: 30718312
[TBL] [Abstract][Full Text] [Related]
7. Lymph node counts in endometrial cancer: expectations versus reality.
Euscher ED; Bassett R; Malpica A
Am J Surg Pathol; 2011 Jun; 35(6):913-8. PubMed ID: 21566518
[TBL] [Abstract][Full Text] [Related]
8. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.
Geppert B; Lönnerfors C; Bollino M; Persson J
Gynecol Oncol; 2018 Mar; 148(3):491-498. PubMed ID: 29273307
[TBL] [Abstract][Full Text] [Related]
10. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
[TBL] [Abstract][Full Text] [Related]
11. To what extent should para-aortic lymphadenectomy be carried out for surgically staged endometrial cancer?
Dogan NU; Gungor T; Karsli F; Ozgu E; Besli M
Int J Gynecol Cancer; 2012 May; 22(4):607-10. PubMed ID: 22546819
[TBL] [Abstract][Full Text] [Related]
12. Postoperative Lower Extremity Edema in Patients with Primary Endometrial Cancer.
Bae HS; Lim MC; Lee JS; Lee Y; Nam BH; Seo SS; Kang S; Chung SH; Kim JY; Park SY
Ann Surg Oncol; 2016 Jan; 23(1):186-95. PubMed ID: 25986870
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of the diameter of metastatic lymph nodes in apparently early stage endometrial cancer.
Boran N; Akdag D; Halici F; Tulunay G; Turan T; Bozok S; Erdogan Z; Kose MF
Tumori; 2008; 94(5):681-5. PubMed ID: 19112940
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the number of pelvic and para-aortic lymph nodes removed in surgical treatment of endometrial and ovarian cancer.
Hareyama H; Ito K; Watanabe S; Hakoyama M; Uchida A; Oku K; Watanabe Y; Hayakashi Y; Hirayama E; Okuyama K
Int J Gynecol Cancer; 2012 Nov; 22(9):1577-84. PubMed ID: 23060049
[TBL] [Abstract][Full Text] [Related]
15. Survival advantage of lymphadenectomy in endometrial cancer.
Eggemann H; Ignatov T; Kaiser K; Burger E; Costa SD; Ignatov A
J Cancer Res Clin Oncol; 2016 May; 142(5):1051-60. PubMed ID: 26746654
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
[TBL] [Abstract][Full Text] [Related]
17. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
[TBL] [Abstract][Full Text] [Related]
18. Patterns of recurrence in endometrial cancer patients at risk of lymph node metastasis or recurrence according to extent of lymphadenectomy.
Kim HJ; Kim TJ; Song T; Kim MK; Lee YY; Choi CH; Lee JW; Bae DS; Kim BG
Int J Gynecol Cancer; 2012 May; 22(4):611-6. PubMed ID: 22398712
[TBL] [Abstract][Full Text] [Related]
19. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
Roger N; Zafrani Y; Uzan C; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
[TBL] [Abstract][Full Text] [Related]
20. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
Venigalla S; Chowdhry AK; Shalowitz DI
Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
